Assert-IQ vs CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Abbott
VS

AI Verdict

Assert-IQ is an insertable cardiac monitor focused on long-term, continuous arrhythmia detection and remote patient management. In contrast, the CARTO™ 3 EP Navigation System is a 3D cardiac mapping and navigation system designed for real-time use by electrophysiologists during interventional procedures. While both address heart rhythm disorders, Assert-IQ serves diagnostic and long-term monitoring needs, whereas CARTO 3 is a procedural guidance tool within the EP lab.

Choose Assert-IQ if…

Choose Assert-IQ if your primary need is long-term, continuous monitoring for patients with suspected, infrequent, or transient heart rhythm disorders that are difficult to capture with shorter-term methods. This system is ideal for comprehensive, remote arrhythmia detection and diagnosis over several years, providing proactive alerts and patient-activated symptom logging to aid in identifying elusive cardiac events.

View Assert-IQ →

Choose CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00 if…

Choose CARTO™ 3 EP Navigation System Software V8.0 if your electrophysiology lab requires an advanced, AI-powered 3D cardiac mapping and navigation system for the precise diagnosis and interventional treatment of complex arrhythmias like AFib and VT. This tool is best suited for guiding catheter-based ablation procedures, offering real-time anatomical mapping, accurate catheter visualization, and enhanced signal analysis to optimize procedural outcomes.

View CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Assert-IQ CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00
Deployment Subcutaneously implanted device with mobile app connectivity On-premise (system with specialized hardware)
FDA Status Cleared AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Assert-IQ

Assert-IQ focuses on patient ease of use with a minimally invasive insertion and a patient activator for symptom logging, along with remote monitoring capabilities. While CARTO 3 streamlines complex EP procedures for specialists, Assert-IQ's broader and simpler interaction for patients and remote monitoring staff gives it an edge in general usability.

Clinical Value

CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00

CARTO 3 EP Navigation System Software V8.0 offers advanced AI/deep learning for real-time 3D cardiac mapping, signal analysis, and substrate characterization, directly enhancing the precision and success of complex interventional ablation procedures. While Assert-IQ provides significant value in long-term diagnosis and management, CARTO 3's immediate impact on high-stakes interventions provides a higher clinical value in its specific domain.

Pricing & Value

Tie

Both tools have opaque enterprise pricing models that require direct contact with the vendor, and neither offers a free trial. Without specific pricing details or publicly available comparative ROI studies, it is not possible to definitively determine which offers better value.

Enterprise Readiness

Tie

Both Assert-IQ and CARTO 3 are products from major, established medical device companies (Abbott and Johnson & Johnson subsidiary, respectively) and are designed for large healthcare systems. Both are HIPAA compliant (or have BAA for cloud components) and offer deployment options suitable for enterprise environments, indicating strong readiness for large-scale adoption.

Innovation

CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00

CARTO 3 demonstrates a higher degree of cutting-edge AI innovation, explicitly leveraging machine learning and deep learning for advanced real-time 3D cardiac mapping, signal analysis, and automated anatomical creation during complex interventional procedures. Assert-IQ's innovation lies in long-term remote monitoring and advanced detection algorithms, but CARTO 3's application of AI in real-time surgical navigation is more advanced.

Support & Docs

Tie

Both Abbott and Biosense Webster (a Johnson & Johnson company) are leading medical device manufacturers with extensive resources. Web searches confirm that both companies provide comprehensive professional and patient manuals, technical support, and educational resources for their complex devices. Without specific comparative metrics on the quality or accessibility of their support, it's reasonable to consider them a tie.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Assert-IQ CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00
Name Assert-IQ CARTOu2122 3 EP Navigation System Software V8.0 (FG-5400-00)
Company Abbott Medical Biosense Webster, Inc.
Description The Assert-IQu2122 Insertable Cardiac Monitor (ICM) system provides long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders. The CARTOu2122 3 EP Navigation System Software V8.0 by Biosense Webster is an FDA-cleared, AI-powered 3D cardiac mapping and navigation system for electrophysiologists, enhancing diagnosis and treatment of heart rhythm disorders like AFib and VT.
Key Features Long-term continuous cardiac monitoring (up to 6 years), Advanced arrhythmia detection algorithms, Bluetoothu00ae Low Energy data transmission, Secure cloud-based data platform, Remote monitoring capabilities, Proactive clinician alerts, Patient activator for symptom logging, Minimally invasive insertion Advanced Catheter Location (ACL) technology for accurate catheter visualization, Fast Anatomical Mapping (FAM) for rapid, high-resolution 3D cardiac maps, Connection of Choice for streamlined workflow and automatic catheter recognition, CARTO ELEVATEu2122 Module with machine learning for enhanced signal analysis and substrate characterization, CARTOSOUNDu2122 FAM Module utilizing AI/deep-learning for automated 3D left atrial anatomy creation, Enhanced CONFIDENSEu2122 Module for optimized map creation and data validation, LAT Velocity Vectors for visualizing activation wave velocity over substrate maps, Stability+ algorithm for continuous analysis of ablation catheter movement
Specialties Cardiology, Internal Medicine Cardiology
Target Size Large health systems, hospitals, cardiology clinics Not specified
AI/Machine Learning Advanced AI algorithms that reduce false positives from AF and Pause episodes while maintaining high sensitivity. AI-powered 3D cardiac mapping and navigation system, CARTO ELEVATEu2122 Module with machine learning for enhanced signal analysis and substrate characterization, CARTOSOUNDu2122 FAM Module utilizing AI/deep-learning for automated 3D left atrial anatomy creation

Videos

Demos, reviews, and walkthroughs featuring Assert-IQ and CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Assert-IQ is an insertable cardiac monitor designed for long-term, continuous monitoring and advanced arrhythmia detection to aid in diagnosing and managing patients with suspected heart rhythm disorders. CARTO 3 EP Navigation System Software V8.0 is a 3D cardiac mapping and navigation system for electrophysiologists, enhancing the diagnosis and treatment of heart rhythm disorders like AFib and VT during interventional procedures.
Assert-IQ is targeted towards cardiologists and internal medicine physicians for diagnostic evaluation and long-term monitoring. CARTO 3 EP Navigation System Software V8.0 is specifically designed for electrophysiologists to use during catheter ablation procedures.
Assert-IQ uses advanced AI algorithms for arrhythmia detection, including reducing false positives for AF and Pause episodes. CARTO 3 EP Navigation System Software V8.0 incorporates machine learning in its CARTO ELEVATEu2122 Module for enhanced signal analysis and substrate characterization, and AI/deep-learning in its CARTOSOUNDu2122 FAM Module for automated 3D left atrial anatomy creation.
The Assert-IQ Insertable Cardiac Monitor system provides long-term continuous cardiac monitoring for up to 6 years. The CARTO 3 EP Navigation System Software V8.0 is used for real-time mapping and navigation during acute electrophysiology procedures.
Assert-IQ involves a minimally invasive insertion procedure and includes a patient activator for symptom logging. CARTO 3 EP Navigation System Software V8.0 is part of a catheter-based system, focusing on accurate catheter visualization and 3D cardiac mapping during interventional procedures.
AI Tool Finder
AI-powered search. Results may not be comprehensive.